InMed Pharmaceuticals Statistics
Total Valuation
INM has a market cap or net worth of $3.57 million. The enterprise value is -$2.90 million.
Important Dates
The last earnings date was Thursday, February 5, 2026, after market close.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INM has 4.07 million shares outstanding. The number of shares has increased by 699.74% in one year.
| Current Share Class | 2.92M |
| Shares Outstanding | 4.07M |
| Shares Change (YoY) | +699.74% |
| Shares Change (QoQ) | +165.01% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 3.64% |
| Float | 2.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.55 |
| Forward PS | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.94, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.94 |
| Quick Ratio | 4.85 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -392.09 |
Financial Efficiency
Return on equity (ROE) is -97.20% and return on invested capital (ROIC) is -56.82%.
| Return on Equity (ROE) | -97.20% |
| Return on Assets (ROA) | -49.77% |
| Return on Invested Capital (ROIC) | -56.82% |
| Return on Capital Employed (ROCE) | -80.75% |
| Weighted Average Cost of Capital (WACC) | 5.97% |
| Revenue Per Employee | $346,661 |
| Profits Per Employee | -$589,566 |
| Employee Count | 13 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 3.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.59% in the last 52 weeks. The beta is 0.39, so INM's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -72.59% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 2.07 |
| Relative Strength Index (RSI) | 32.40 |
| Average Volume (20 Days) | 62,894 |
Short Selling Information
The latest short interest is 165,213, so 4.06% of the outstanding shares have been sold short.
| Short Interest | 165,213 |
| Short Previous Month | 122,759 |
| Short % of Shares Out | 4.06% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 1.91 |
Income Statement
In the last 12 months, INM had revenue of $4.51 million and -$7.66 million in losses. Loss per share was -$2.73.
| Revenue | 4.51M |
| Gross Profit | 1.34M |
| Operating Income | -7.84M |
| Pretax Income | -7.66M |
| Net Income | -7.66M |
| EBITDA | -7.63M |
| EBIT | -7.84M |
| Loss Per Share | -$2.73 |
Full Income StatementBalance Sheet
The company has $7.00 million in cash and $531,949 in debt, with a net cash position of $6.47 million or $1.59 per share.
| Cash & Cash Equivalents | 7.00M |
| Total Debt | 531,949 |
| Net Cash | 6.47M |
| Net Cash Per Share | $1.59 |
| Equity (Book Value) | 9.59M |
| Book Value Per Share | 3.42 |
| Working Capital | 7.31M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.55M |
| FCF Per Share | -$1.85 |
Full Cash Flow StatementMargins
Gross margin is 29.73%, with operating and profit margins of -174.01% and -170.07%.
| Gross Margin | 29.73% |
| Operating Margin | -174.01% |
| Pretax Margin | -170.07% |
| Profit Margin | -170.07% |
| EBITDA Margin | -169.32% |
| EBIT Margin | -174.01% |
| FCF Margin | n/a |
Dividends & Yields
INM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -699.74% |
| Shareholder Yield | -699.74% |
| Earnings Yield | -214.75% |
| FCF Yield | -211.48% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 14, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
INM has an Altman Z-Score of -14.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.76 |
| Piotroski F-Score | 2 |
